Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies

Mayo Clinic Proceedings

Volumn 91, Issue 11, 2016, Pages 1632-1639

  Markota, Matej ^a   Rummans, Teresa A ^a   Bostwick, John Michael ^a   Lapid, Maria I ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; CLONAZEPAM; DIPHENHYDRAMINE; DOXEPIN; DOXYLAMINE; DULOXETINE; ESCITALOPRAM; ESZOPICLONE; MIRTAZAPINE; SERTRALINE; TRAZODONE; VALPROIC ACID; ZALEPLON; ZOLPIDEM; ANTIDEPRESSANT AGENT; DELAYED RELEASE FORMULATION;

ANXIETY DISORDER; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COGNITIVE BEHAVIORAL THERAPY; COGNITIVE DEFECT; DELIRIUM; DEMENTIA; DOCTOR PATIENT RELATION; DRUG DEPENDENCE; DRUG SAFETY; EVIDENCE BASED MEDICINE; FALLING; FRACTURE; GENERALIZED ANXIETY DISORDER; GERIATRIC PATIENT; HEALTH CARE ACCESS; HUMAN; INSOMNIA; MORTALITY RATE; PATIENT EDUCATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY HEALTH CARE; REVIEW; SEIZURE; SEX DIFFERENCE; SLEEP DISORDER; TRAFFIC ACCIDENT; TREATMENT INDICATION; TREATMENT WITHDRAWAL; WITHDRAWAL SYNDROME; AGED; ANXIETY; CHEMICALLY INDUCED; COGNITIVE THERAPY; DELAYED RELEASE FORMULATION; DOSE RESPONSE; DRUG ADMINISTRATION; FRACTURES, BONE; INAPPROPRIATE PRESCRIBING; PSYCHOLOGY; SLEEP INITIATION AND MAINTENANCE DISORDERS;

ACCIDENTAL FALLS; AGED; ANTIDEPRESSIVE AGENTS; ANXIETY; BENZODIAZEPINES; COGNITION DISORDERS; COGNITIVE THERAPY; DELAYED-ACTION PREPARATIONS; DEMENTIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FRACTURES, BONE; HUMANS; INAPPROPRIATE PRESCRIBING; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 84995598519     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2016.07.024     Document Type: Review

References (25)

1. 1 American Geriatrics Society 2015 Beers Criteria Update Expert Panel, American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63:11 (2015), 2227–2246.
2. 2 College of Psychiatry of Ireland. A consensus paper on the use of benzodiazepines in specialist mental health services. College of Psychiatry of Ireland website. http://www.irishpsychiatry.ie/Home.aspx. Published June 2012. Accessed April 27, 2016.
3. 3 Olfson, M., King, M., Schoenbaum, M., Benzodiazepine use in the United States. JAMA Psychiatry 72:2 (2015), 136–142.
4. 4 Weisberg, R.B., Dyck, I., Culpepper, L., Keller, M.B., Psychiatric treatment in primary care patients with anxiety disorders: a comparison of care received from primary care providers and psychiatrists. [published correction appears in Am J Psychiatry. 2007;164(5):833] Am J Psychiatry 164:2 (2007), 276–282.
5. 5 Anderson, K., Stowasser, D., Freeman, C., Scott, I., Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open, 4(12), 2014, e006544.
6. 6 Marra, E.M., Mazer-Amirshahi, M., Brooks, G., van den Anker, J., May, L., Pines, J.M., Benzodiazepine prescribing in older adults in U.S. ambulatory clinics and emergency departments (2001-10). J Am Geriatr Soc 63:10 (2015), 2074–2081.
7. 7 Hill, K.D., Wee, R., Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem. Drugs Aging 29:1 (2012), 15–30.
8. 8 Bakken, M.S., Engeland, A., Engesæter, L.B., Ranhoff, A.H., Hunskaar, S., Ruths, S., Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. Eur J Clin Pharmacol 70:7 (2014), 873–880.
9. 9 Cumming, R.G., Le Couteur, D.G., Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 17:11 (2003), 825–837.
10. 10 Moore, N., Pariente, A., Bégaud, B., Why are benzodiazepines not yet controlled substances [editorial]?. JAMA Psychiatry 72:2 (2015), 110–111.
11. 11 Xing, D., Ma, X.L., Ma, J.X., Wang, J., Yang, Y., Chen, Y., Association between use of benzodiazepines and risk of fractures: a meta-analysis. Osteoporos Int 25:1 (2014), 105–120.
12. 12 American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 5th ed., 2013, American Psychiatric Association, Arlington, VA, 553.
13. 13 Rummans, T.A., Davis, L.J. Jr., Morse, R.M., Ivnik, R.J., Learning and memory impairment in older, detoxified, benzodiazepine-dependent patients. Mayo Clin Proc 68:8 (1993), 731–737.
14. 14 Barker, M.J., Greenwood, K.M., Jackson, M., Crowe, S.F., Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol 19:3 (2004), 437–454.
15. 15 Zhong, G., Wang, Y., Zhang, Y., Zhao, Y., Association between benzodiazepine use and dementia: a meta-analysis. PLoS One, 10(5), 2015, e0127836.
16. 16 Palmaro, A., Dupouy, J., Lapeyre-Mestre, M., Benzodiazepines and risk of death: results from two large cohort studies in France and UK. Eur Neuropsychopharmacol 25:10 (2015), 1566–1577.
17. 17 Tannenbaum, C., Martin, P., Tamblyn, R., Benedetti, A., Ahmed, S., Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med 174:6 (2014), 890–898.
18. 18 Darker, C.D., Sweeney, B.P., Barry, J.M., Farrell, M.F., Donnelly-Swift, E., Psychosocial interventions for benzodiazepine harmful use, abuse or dependence. Cochrane Database Syst Rev, 5, 2015, CD009652.
19. 19 Paquin, A.M., Zimmerman, K., Rudolph, J.L., Risk versus risk: a review of benzodiazepine reduction in older adults. Expert Opin Drug Saf 13:7 (2014), 919–934.
20. 20 Denis, C., Fatséas, M., Lavie, E., Auriacombe, M., Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Cochrane Database Syst Rev(3), 2006, CD005194.
21. 21 Rickels, K., Schweizer, E., Garcia España, F., Case, G., DeMartinis, N., Greenblatt, D., Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome. Psychopharmacology (Berl) 141:1 (1999), 1–5.
22. 22 Wright, A., Diebold, J., Otal, J., et al. The effect of melatonin on benzodiazepine discontinuation and sleep quality in adults attempting to discontinue benzodiazepines: a systematic review and meta-analysis. Drugs Aging 32:12 (2015), 1009–1018.
23. 23 Bloom, H.G., Ahmed, I., Alessi, C.A., et al. Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Geriatr Soc 57:5 (2009), 761–789.
24. 24 Bostwick, J.M., A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy. Mayo Clin Proc 85:6 (2010), 538–550.
25. 25 Stanley, M.A., Wilson, N.L., Novy, D.M., et al. Cognitive behavior therapy for generalized anxiety disorder among older adults in primary care: a randomized clinical trial. JAMA 301:14 (2009), 1460–1467.